Autor: Bianca Lamarca da Cruz

Resumo: The Institute of Nuclear Engineering has a radiopharmaceutical production sector that manufactures ultrapure Iodine-123 for medical applications, using the CV-28 cyclotron accelerator. The particle beam is driven to the target sample to be irradiated, that is placed in a own concret cave placed 15 m away from CV-28. This target cave, where a xenon-124 gas target is positioned, reaches the dose level limits set out by the Brazilian National Nuclear Energy Commission Standard 3.01[1] in its surrounding ar

Download do Artigo